| Nov 12 |
Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
| Nov 12 |
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 12 |
Natera stock jumps 11% post-market on Q3 earnings, raised guidance
|
| Nov 12 |
Natera: Q3 Earnings Snapshot
|
| Nov 12 |
Natera GAAP EPS of -$0.26 beats by $0.33, revenue of $439.76M beats by $78.63M
|
| Nov 12 |
Natera Reports Third Quarter 2024 Financial Results
|
| Nov 12 |
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Natera Q3 2024 Earnings Preview
|
| Nov 8 |
Natera to Participate in Upcoming Investor Conferences
|
